Health Care Department Operations Manual

Cancel

Chapter 3 – Health Care Operations

Article 3.2 – Dental Care: Scope of Services

View All Sections >

3.3.2.5 Periodontal Disease Program for Pregnant Patients

  • Policy

    • Within the second trimester of gestation, pregnant California Department of Corrections and Rehabilitation patients shall receive a comprehensive dental examination, periodontal examination and the necessary periodontal treatment in order to maintain periodontal health during the gestation period.

  • Purpose

    • To establish protocols which prevent or treat gingivitis or periodontitis during pregnancy.

  • Procedure

    • Pregnant patients shall benefit from the periodontal disease program as delineated here and in the Health Care Department Operations Manual (HCDOM), Section 3.3.2.4, Periodontal Disease Program.

    • Diagnosis of Periodontal Disease

      • Pregnant patients shall receive a comprehensive periodontal examination, charting and classification to determine their periodontal condition and an appropriate treatment plan.

      • Pregnant patients shall have their plaque index (PI) score determined and recorded as outlined in the HCDOM, Section 3.3.2.13(c)(2).

    • Treatment of Periodontal Disease

      • Education

        • Methods and procedures to control periodontal disease shall be taught and demonstrated to pregnant patients by dental staff as outlined in the HCDOM, Section 3.3.2.4(c)(2)(C)1.a.

      • Clinical Treatment

        • Pregnant patients shall receive a prophylaxis or scaling and/or root planing regardless of their ability to maintain an acceptable PI score. This treatment shall occur within their second trimester of gestation. A charting and re-evaluation of their periodontal condition shall be accomplished approximately 30 calendar days following completion of prophylaxis or scaling and/or root planing procedures with subsequent care planned as needed.

        • The attending dentist shall not utilize subgingival periodontal medications (e.g., Atridox, Periostat) that are contraindicated for use during pregnancy.

  • Revision History

    • Effective: 04/2006
      Revised: 11/2017
      Reviewed: 11/2020, 02/2022